We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Molecular Diagnostics

Image: New findings provide strong evidence that Barrett’s esophagus initiates esophageal adenocarcinoma and identify markers for earlier detection (photo courtesy of Shutterstock)

Study Confirms Barrett’s Esophagus as Precursor to Esophageal Cancer

New findings confirm Barrett’s esophagus initiates esophageal adenocarcinoma and highlight markers for nonendoscopic detection. More...
16 Apr 2026
Image: Flow chart summarizing workflow pipeline (Thomas, V., Nyamundanda, G., Lärkeryd, A. et al. Sci Rep 16, 8843 (2026). https://doi.org/10.1038/s41598-026-39189-w)

AI Tool Predicts Bevacizumab Non-Response in Metastatic Colorectal Cancer

An AI approach fusing genomic and clinical data stratifies bevacizumab-treated metastatic CRC, flagging likely non-responders. More...
15 Apr 2026
Image: The PrepQuant System is assay-agnostic and generates highly concentrated genomic DNA and cfDNA suitable for NGS, qPCR and dPCRassays (photo courtesy of 123RF)

Automated Sample Preparation System Standardizes Pre-Analytical Workflow for MRD and Liquid Biopsy

A new system unifies extraction, concentration, and quantification to standardize pre-analytical workflows and cut variability. More...
15 Apr 2026
Image: Dengue is among the most widespread mosquito-borne infections, yet early risk stratification can be difficult when symptoms overlap with other febrile illnesses (photo courtesy of Adobe Stock)

Urine-Based Assay Predicts Severe Dengue Risk Early

A new urine test measures two inflammation-associated proteins to predict severe dengue earlier, outperforming warning signs to guide triage. More...
14 Apr 2026
Image: Elecsys NfL is an in vitro quantitative immunoassay that measures neurofilament light chain protein concentrations in human serum and plasma (photo courtesy of Roche)

CE-Marked Blood Test Enables Monitoring of Neuroinflammation in Multiple Sclerosis

Roche’s Elecsys Neurofilament Light Chain (NfL) test has received CE mark approval for use in adults diagnosed with relapsing‑remitting multiple sclerosis (RRMS). More...
14 Apr 2026
Image: Personalis’ NeXT Personal ultrasensitive ctDNA assay will be featured alongside the debut of Real‑Time Variant Tracker at the AACR Annual Meeting 2026 in San Diego (photo courtesy of Personalis)

Ultrasensitive Assay Tracks Resistance Mutations MRD Monitoring

A new ctDNA MRD test tracks resistance mutations and detects down to 10 ppm to predict immunotherapy response and relapse. More...
14 Apr 2026
Image: This diagram outlines the dual potential of EV-RNAs in IBD: as non-invasive biomarkers for early diagnosis and monitoring, and as carriers of regulatory RNAs to target inflammation, repair the epithelial barrier, and restore gut homeostasis. (Ruizhe Ren/Zhejiang Chinese Medical University, Xiyang Wei/Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine)

Extracellular Vesicle RNA Biomarkers Enable Noninvasive IBD Diagnosis and Monitoring

EV‑RNA biomarkers show promise for noninvasive monitoring and treatment of inflammatory bowel disease. More...
13 Apr 2026
Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Manual Pipetting Aid
Pipette Controllers macro
Electrolyte Analyzer
CBS-4000 (CBS-400)


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.